London, January 2
Amidst growing pressure over sufficient supplies of Covid vaccines in the UK, pharmaceutical companies have hit back at government claims that access to enough jabs was a “limiting factor”, insisting there was no issue at their end.
While AstraZeneca says it expects 2 million doses of the Oxford University vaccine to be ready each week in just over a fortnight, Pfizer BioNTech said the number of doses it has now sent to the UK is “in the millions”. The Pfizer and Oxford/AstraZeneca jabs are the two vaccines against Covid that are approved for rollout in the UK.
“The plan is then to build it up fairly rapidly; by the third week of January we should get to 2 million a week,” an AstraZeneca source said. “The deliveries to the UK are on track and progressing according to our agreed schedule,” a Pfizer spokesperson said.
Meanwhile, there are growing questions on whether Britain could have had more supplies ready to go, similar to how India has created a massive vaccine stockpile in advance, according to The Daily Telegraph.
Pune-based Serum Institute of India has a licensing tie-up for the Oxford vaccine. It has emerged that India has already managed to stockpile 50 million doses of the jabs. — Agencies